AstraZeneca Releases COVID - 19 Vaccine Trial Plans
Serious neurological illnesses have led the company to halt its trials twice
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Institutional, Source Type: news
More News: AstraZeneca | Brain | COVID-19 | Emergency Medicine | Internal Medicine | Neurology | Nurses | Nursing | Pathology | Respiratory Medicine | Vaccines